-
31 July 2022
Global Fund Reports Significant Progress in Breaking Down Human Rights-Related Barriers to HIV and TB Services
-
29 July 2022
As Progress Against HIV Slows, Global Fund Calls for Accelerated Investments in Innovations
The Global Fund to Fight AIDS, Tuberculosis and Malaria is deeply concerned about the slowdown of the global fight against HIV. A new UNAIDS report released this week at the International AIDS Conference in Montreal shows that progress against the di... -
23 June 2022
Global Fund Applauds Goodbye Malaria’s Contribution to Seventh Replenishment
The Global Fund welcomes Goodbye Malaria’s renewed commitment to the fight against AIDS, tuberculosis (TB) and malaria with a new pledge of US$5.5 million (ZAR 88 million) for the Global Fund’s Seventh Replenishment. -
31 May 2022
Luxembourg Increases Pledge by 30% for Global Fund’s Seventh Replenishment
The Global Fund to Fight AIDS, Tuberculosis and Malaria warmly welcomes today's announcement by Luxembourg of a €11.7 million pledge for the upcoming three-year period, a 30% increase in Luxembourg’s contributions to the Global Fund from the previous... -
24 May 2022
Global Fund and Partners Urge Increased Investment Towards Ending World’s Deadliest Diseases, Welcome First Private Sector Pledge
Ahead of the Global Fund’s Seventh Replenishment Conference, the Global Fund and partners called on all players in the private sector – philanthropists, foundations, and corporations – for a step-change in their commitment to ending AIDS, tuberculosi... -
20 May 2022
Global Fund Signs Letter of Intent with Pfizer for Oral COVID-19 Treatment
The Global Fund has signed a letter of intent with Pfizer for the procurement of up to 6 million treatment courses of the new oral antiviral medicine nirmatrelvir/ritonavir, sold under the name PAXLOVID™, in 2022-2023. -
13 May 2022
Global Fund Thanks European Union and Team Europe for Their Contribution to COVID-19 Response Mechanism
The Global Fund to Fight AIDS, Tuberculosis and Malaria thanks the European Union and Team Europe for their contribution to the Global Fund's COVID-19 Response Mechanism (C19RM). The President of the European Commission, Ursula von der Leyen, announc... -
13 May 2022
Global Fund Board Calls for Global Mobilization Ahead of Crucial Seventh Replenishment and Gets Ready for Implementation of New Strategy
The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria held its 47th Board meeting this week in Geneva. A few months ahead of the Global Fund’s Seventh Replenishment Conference to be hosted by the United States, the Board renewed its ca... -
13 May 2022
Global Fund Applauds New Zealand’s Commitment to COVID-19 Response Mechanism
The Global Fund to Fight AIDS, Tuberculosis and Malaria applauds the decision by New Zealand to contribute NZ$8 million to the Global Fund's COVID-19 Response Mechanism (C19RM). The new funding will help provide lifesaving diagnostic tests, treatment... -
12 May 2022
Global Fund, United States and Unitaid Launch “Test-and-Treat” Programs at Second Global COVID-19 Summit
The Global Fund, the United States and Unitaid, together with FIND and other ACT-Accelerator partners, are launching over US$120 million in support to countries for test-and-treat programs to prevent hospitalizations and deaths from COVID-19 for thos...